INTERNATIONAL PATENT: ELIXIRON IMMUNOTHERAPEUTICS INC., CHEN, HUNG-KAI FILES APPLICATION FOR "METHOD OF ENHANCED ABSORPTION OF QUINOXALINE TYPE III RECEPTOR TYROSINE KINASE INHIBITORS"

GENEVA, Jan. 29 -- ELIXIRON IMMUNOTHERAPEUTICS INC. (Rm. 3, 16F., No. 508, Sec. 7, Zhongxiao E. Rd.Nangang Dist.Taipei City 115011), CHEN, Hung-Kai (1507 Richardson ave.Los Altos, CA 94024) filed a patent application (PCT/US2024/038448) for "METHOD OF ENHANCED ABSORPTION OF QUINOXALINE TYPE III RECEPTOR TYROSINE KINASE INHIBITORS" on Jul 18, 2024. With publication no. WO/2025/019622, the details related to the patent application was published on Jan 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ELIXIRON IMMUNOTHERAPEUTICS INC. (Rm. 3, 16F., No. 508, Sec. 7, Zhongxiao E. Rd.Nangang Dist...